Reactive phenotypes after acute and chronic NK-cell activation

Journal of Biological Regulators and Homeostatic Agents

Volumn 18, Issue 3-4, 2004, Pages 331-334

  Lima, Margarida ^a   Almeida, J ^b   Teixeira, M A ^a   Santos, A H ^a   Queiros M L ^a   Fonseca, S ^a   Moura, J ^a   Goncalves M ^a   Orfao A ^b   Pinto Ribeiro, A C ^a  

^a HOSPITAL DE SANTO ANTÓNIO   (Portugal)

^b Centro de Investigacion del Cancer   (Spain)

Author keywords

Activation; Flow cytometry; NK cells; Phenotype

Indexed keywords

ARTICLE; CELL KILLING; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE MIGRATION; LYMPHOCYTE PROLIFERATION; NATURAL KILLER CELL; PHENOTYPE; REGULATORY MECHANISM; IMMUNOLOGY; IMMUNOPHENOTYPING; T LYMPHOCYTE;

CD56 ANTIGEN;

ANTIGENS, CD56; HUMANS; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES;

EID: 21144440686     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Rabinowich H, Herberman RB, Whiteside TL. Differential effects of IL12 and IL2 on expression and function of cellular adhesion molecules on purified human natural killer cells. Cell Immunol 1993; 152: 481-98.
2. Rabinowich H, Sedlmayr P, Herberman RB, Whiteside TL. Response of human NK cells to IL-6 alterations of the cell surface phenotype, adhesion to fibronectin and laminin, and tumor necrosis factor-alpha/beta secretion. J Immunol 1993; 150: 4844-55.
3. Carbone E, Ruggiero G, Terrazzano G, et al. A new mechanism of NK cell cytotoxicity activation: the CD40-CD40 ligand interaction. J Exp Med 1997; 185: 2053-60.
4. Nakarai T, Robertson MJ, Streuli M, et al. Interleukin 2 receptor gamma chain expression on resting and activated lymphoid cells. J Exp Med 1994; 180: 241-51.
5. Warren HS, Skipsey LJ. Loss of activation-induced CD45RO with maintenance of CD45RA expression during prolonged culture of T cells and NK cells. Immunology 1991; 74: 78-85.
6. Robertson MJ, Caligiuri MA, Manley TJ, Levine H, Ritz JR Human natural killer cell adhesion molecules. Differential expression after activation and participation in cytolysis. J Immunol. 1990; 145: 3194-201.
7. Yamabe T, Takakura K, Sugie K, et al. Induction of the 2B9 antigen/dipeptidyl peptidase IV/CD26 on human natural killer cells by IL-2, IL-12 or IL-15. Immunology 1997; 91: 151-8.
8. Maenpaa A, Jaaskelainen J, Carpen O, Patarroyo M, Timonen T. Expression of integrins and other adhesion molecules on NK cells; impact of IL-2 on short- and long-term cultures. Int J Cancer 1993; 53: 850-5.
9. Umehara H, Minami Y, Domae N, Bloom ET. Increased processing of lymphocyte function-associated antigen-1 in human natural killer cells stimulated with IL-2. Int Immunol 1994; 6: 1071-80.
10. Baume DM, Caligiuri MA, Manley TJ, Daley JF, Ritz J. Differential expression of CD8 alpha and CD8 beta associated with MHC-restricted and non-MHC-restricted cytolytic effector cells. Cell Immunol 1990; 131: 352-65.
11. Anderson P, Caligiuri M, O'Brien C, Manley T, Ritz J, Schlossman SF. Fc gamma receptor type III (CD16) is included in the zeta NK receptor complex expressed by human natural killer cells. Proc Natl Acad Sci USA 1990; 87: 2274-8.
12. Vujanovic NL, Rabinowich H, Lee YJ, Jost L, Heberman RB, Whiteside TL. Distinct phenotypic and functional characteristics of human natural killer cells obtained by rapid interleukin 2-induced adherence to plastic. Cell Immunol 1993; 151: 133-57.
13. Cordero OJ, Sarandeses C, Lopez-Rodriguez JL, Nogueira M. The presence and cytotoxicity of CD16+ CD2- subset from PBL and NK cells in long-term IL-2 cultures enhanced by prothymosin-alpha. Immunopharmacology 1995; 29: 215-23.
14. Lima M, Teixeira MA, Queirós ML et al. Immunophenotypic characterization of normal blood CD56+Io versus CD56+high NK-cell subsets and its impact of the understanding of their tissue distribution and functional properties. Blood Cells Mol Dis 2001; 27: 731-43.
15. Lima M, Almeida J, Teixeira MA, Queirós ML, Justiça B, Orfão A. The ex vivo Patterns of CD2/CD7, CD57/CD11c, CD38/CD11b, CD45RA/CD45RO, and CD11a /HLA-DR Expression Identify Acute/Early and Chronic/Late NK-Cell Activation States. Blood Cells Mol Dis 2002; 28: 181-90.
16. Lima M, Teixeira MA, Queirós ML, et al. Immunophenotype and TCR-Vb repertoire of peripheral blood T-cells in acute infectious mononucleosis. Blood Cells Mol Dis 2003; 30: 1-12.
17. Lima M, Almeida J, García Montero A, et al. Clinicobiological, immunophenotypic and molecular characteristics of monoclonal CD56-/+dim Chronic NK-cell Large Granular Lymphocytosis. Am J Pathol 2004; 165: 1117-27.